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Functional biomolecules, including small noncoding
RNAs (ncRNAs), are released and transmitted be-
tween mammalian cells via extracellular vesicles
(EVs), including endosome-derived exosomes. The
small RNA composition in cells differs from exo-
somes, but underlying mechanisms have not been
established. We generated small RNA profiles by
RNA sequencing (RNA-seq) from a panel of human
B cells and their secreted exosomes. A comprehen-
sive bioinformatics and statistical analysis revealed
nonrandomly distributed subsets of microRNA
(miRNA) species between B cells and exosomes. Un-
expectedly, 30 end adenylated miRNAs are relatively
enriched in cells, whereas 30 end uridylated isoforms
appear overrepresented in exosomes, as validated in
naturally occurring EVs isolated from human urine
samples. Collectively, our findings suggest that post-
transcriptional modifications, notably 30 end adeny-
lation and uridylation, exert opposing effects that
may contribute, at least in part, to direct ncRNA sort-
ing into EVs.
INTRODUCTION
The human genome encodes for a vast amount of small non-
protein-coding RNA (ncRNAs) transcripts. Multiple ncRNA
classes exist that include the highly abundant tRNAs, rRNAs,
small nucleolar RNAs, microRNAs (miRNAs), small interfering
RNAs, small nuclear RNAs, and piwi-interacting RNAs (piRNAs)
(Amaral et al., 2008; Martens-Uzunova et al., 2013). The 22 nt
long miRNAs gained much attention acting as potent transla-
tional repressors by binding to target mRNAs by sequence com-
plementary (Ameres et al., 2007). The activity of miRNAs isCell Rerelated to their concentration in the cytoplasm and interaction
with RNA-induced silencing complexes (RISC) (Mullokandov
et al., 2012). Subtle alterations in the levels of miRNAs may
already influence cellular processes, whereas strong perturba-
tions can cause disease. Besides abundance RNA-binding pro-
teins, RNA partners and subcellular localization are additional
factors controlling miRNA physiology (Wee et al., 2012).
We previously reported that Epstein-Barr virus (EBV)-trans-
formed lymphoblastoid B cells (LCLs) constitutively secrete large
quantities of endosome-derived exosomes that incorporate both
human and viral miRNAs. Copy-number measurements demon-
strated that these exosomes mediate cell-cell transmission of
miRNAs, leading to viral miRNA accumulation in recipient cells
and target mRNA repression (Pegtel et al., 2010). Together
with following observations using different systems, they
strongly suggest that miRNA transfer via exosomes can have a
role in cell-cell communication (Mittelbrunn and Sa´nchez-
Madrid, 2012). Small RNAs are presumably sorted into exo-
somes at endosomal membranes because interfering with their
formation affects functional transfer (Kosaka et al., 2013; Mittel-
brunn et al., 2011; Okoye et al., 2014). Although secretion of
miRNAs with extracellular vesicles (EVs) may occur in a
nonrandom fashion (Bellingham et al., 2012; Nolte-’t Hoen
et al., 2012), a thorough comparative analysis in purified exo-
some populations and the producing cells has been lacking.
Demonstrating potential mechanisms for selective sorting of
small RNAs into exosomes would be relevant to understand their
gene-regulatory function in both the producing and recipient
cells (Pegtel et al., 2011) and may provide clues on their mobility
in living organisms (Chitwood and Timmermans, 2010).
In a prior study, we observed that certain miRNA species are
precluded from exosome incorporation, suggesting selection
of miRNA for exosomal release. Because RISC complexes are
physically and functionally coupled to endosomal membranes
in flies and humans (Gibbings et al., 2009; Lee et al., 2009) and
because GW182 knockdown reduces miRNA secretion through
exosomes (Yao et al., 2012), it appears that intracellularports 8, 1649–1658, September 25, 2014 ª2014 The Authors 1649
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Figure 1. Small RNA Repertoire from B Cells and Their Exosomes
(A) cDNA libraries were generated from cellular and exosomal small RNA fractions. Sample groups, cell lines, and a type of sample fraction are indicated (see also
Table S1A).
(B) All mapped reads from cellular and exosomal fractions are grouped by annotation to RNA transcripts of origin and presented as distribution frequency of
mapped reads in percentage.
C) Heatmap showing the pairwise Spearman (rank) correlation between miRNAs expression per 12 libraries. Upper left square: LCL cells (n = 3; r = 0.76–0.8);
lower right square: LCL exosomes (n = 3; r = 0.72–0.76).trafficking, localization, and activity control small ncRNA release.
Recent studies suggest that nontemplate terminal nucleotide
additions (NTAs) predispose miRNA association with RISC (Bur-
roughs et al., 2010; Polikepahad and Corry, 2013), affecting their
stability, turnover, and activity (Ameres et al., 2010; Baccarini
et al., 2011; Boele et al., 2014; Jones et al., 2009). Because
adenylation effects the stability and activity of certain miRNAs
(Boele et al., 2014; D’Ambrogio et al., 2012), we hypothesized
that nonrandom incorporation of miRNAs into mammalian exo-
somes could be coupled to their activity and posttranscriptional
modification by NTAs.
Here, we report that 30 end adenylation of defined miRNA spe-
cies is correlated with relative enrichment in cells compared to
exosomes. This is consistent with this type of modification hin-
dering incorporation and secretion of these miRNA isoforms
via exosomes. Importantly, we found an opposite behavior for1650 Cell Reports 8, 1649–1658, September 25, 2014 ª2014 The Au30 end uridylatedmiRNA isoforms, which appear enriched in exo-
somes. Our study provides a new understanding of exosomal
small RNA cargo and offers a rationale for studying miRNA pro-
cessing, modification, and turnover in connection to exosome
biology.
RESULTS
Small Noncoding RNA Families Are Differentially
Distributed between B Cells and Exosomes
To determine whether small RNA species of less than 200 nt are
enriched in exosomes, we generated cellular and corresponding
exosomal small RNA libraries for sequencing of EBV-driven
LCLs and B cell lymphoma cell lines (Figure 1A). This approach
provided a comprehensive data set to perform high-powered
statistical analysis on the intra- and extracellular RNA repertoiresthors
within a defined cellular background (individual reads and align-
ment statistics in Table S1). Comparison to RNA reference
libraries revealed that cellular and exosomal small RNA fractions
contained products from diverse classes of RNAs (Figure 1B).
Besides their large diversity, it seems that several RNA classes
are enriched in cells (Figure 1B; black bars), whereas others
are overrepresented in exosomes (gray bars). In all cellular sam-
ples, the class of miRNAs represents around 50% of the small
RNA pool. In exosomes, however, miRNAs appear to be under-
represented (20%) in comparison to other small RNA fragments.
RNA elements derived from the other ncRNA classes (i.e.,
tRNAs, piRNAs, rRNAs, Y RNAs, and vault RNAs) were generally
enriched in the exosomes, even though the class distribution
was distinct between cell types (Figure 1B).
The most striking distinction between LCL and lymphoma
exosomes was the extreme abundance of human Y RNAs frag-
ments (38%; Figures 1B and S1A; p < 0.05). To investigate
whether the enrichment of Y RNA fragments (Figure S2B) reflects
the presence of full-length transcripts, we performed semiquan-
titative RT-PCR on the exosomal RNA that was subjected to
sequencing. We detected high levels of full-length Y RNA spe-
cies (i.e., RNY1, RNY3, RNY4, and RNY5) and vault RNA1-1 (Fig-
ure S2C) in exosomes. These data are consistent with previous
observations in exosomal small RNA sequencing studies (Bel-
lingham et al., 2012; Nolte-’t Hoen et al., 2012; Vojtech et al.,
2014). Although the biological relevance of Y RNAs incorporation
in exosomes is currently unclear, these small regulatory RNAs
seem to be specifically packaged in enveloped and nonenvel-
oped viral particles (Garcia et al., 2009). The selective recruit-
ment of small ncRNAs from the host cell into (retro) viral particles
and exosomes implies that common molecular mechanisms
may drive their packaging process. This realization could aid
future characterization of cellular components governing exo-
somes biogenesis and cargo selection (Koppers-Lalic et al.,
2013).
High and Low Abundant MicroRNAs Are Nonrandomly
Incorporated into Exosomes
To gain more insight into possible disparities between miRNA
distribution in cells versus exosomes, we calculated Spearman
correlations between normalized miRNA reads of all cellular
samples and paired exosomes (n = 12). Cluster analysis sepa-
rated the LCL samples from the lymphoma samples, as
illustrated by the heatmap correlation matrices (Figure 1C;
Spearman correlations [r] = 0.48–0.81 range), showing high level
of correlation between LCL data sets (r = 0.72–0.8).
Next, mappedmiRNA counts were fitted in a generalized linear
model using the R package edgeR (Robinson et al., 2010) and
the relative abundance of individual miRNAs in cells and exo-
somes were compared (Tables S1B and S1C). The most abun-
dant cellular miRNAs (relative expression >10,000 reads per
million [RPM] normalized to the total miRNAs reads) in general
represented the most abundant miRNAs in the exosomes (Table
S1B). Although the miRNA distribution in exosomal fractions is
clearly influenced by cellular miRNA abundance, we identified
a subset of miRNAs that were discordantly distributed between
cells and exosomes (false discovery rate [FDR] < 0.05; Tables
S1B and S1C).Cell ReTo investigate which miRNAs are relatively enriched in LCL,
Burkitt lymphoma (BL), and diffuse large B cell lymphoma
(DLBCL) backgrounds, all miRNAs were grouped according to
the fold enrichment in exosomes versus cellular miRNA reads
(RPM). We determined that the most significant enrichment of
miRNAs was observed in exosomes rather than in cells (Fig-
ure 2A). To assess whether discordantly distributed miRNAs
(Figures 2B and 2C) are detectable by other methodologies,
we performed stem-loop-based quantitative RT-PCR (qRT-
PCR) on RNA extracted from LCL cells and exosomes (LCL1 bio-
logical duplicates). The PCR data analysis showed that human
miRNAs miR-451, miR-127-3p, and miR-410 were relatively
abundant in exosomes fractions, which is consistent with the
RNA sequencing (RNA-seq) approach. Strikingly, miR-451 and
miR-127-3p were barely detectable in cells, in contrast to prefer-
entially cell-enriched miRNAs miR-1275 and miR-744 (Fig-
ure 2D). The enrichment of miR-127-3p in exosomes could be
related to its function as a negative regulator of B cell lymphoma
6mRNA (BCL6), a transcriptional repressor in lymphomagenesis
and miR-127-3p release, could favor the growth and survival of
B cell lymphoma cells (Saito et al., 2006).
Differences in Human and Viral miRNA Distribution
EBV-miRNAs provide essential growth advantages to EBV-
infected proliferating B cells and EBV-driven lymphomas (Qiu
et al., 2011; Seto et al., 2010), and we expected these to be rela-
tively enriched in cells. To analyze the distribution of 44 miRNAs
encoded by EBV in the transformed B cells, we calculated the
fold change (FC) by means of edgeR, i.e., using trimmed mean
ofM values normalization formiRNA reads only. This is illustrated
in Figure 2E, where the majority of viral miRNAs (indicated in red)
have a tendency toward cell enrichment (negative log2 FC). In
contrast to human miRNAs, not a single viral miRNA was found
significantly enriched in exosomes (Figure S2B). EBV-miRNA
abundance varies widely, yet most abundant ones belonged
to the BART cluster miRNAs (Table S1D) that target 132
apoptosis-related cellular mRNAs, in agreement with these
EBV miRNAs promoting B cell survival (Riley et al., 2012).
30 End NTAs Define Retention or Release of miRNAs
In Vitro and In Vivo
Whereas the most abundant miRNA sequence from pre-miRNA
hairpins is usually referred to as the ‘‘mature’’ miRNA (miRBase),
inefficient Drosha or Dicer-mediated processing of pre-miRNAs
produces 30 end length variants (e.g., truncations and elonga-
tions). Additional miRNA isoforms are generated by nucleotidyl
transferase-mediated posttranscriptional modifications known
as nontemplated terminal NTAs (Burroughs et al., 2010; Morin
et al., 2008; Wyman et al., 2011; Figure S3A).
Global analysis of miRNA 30 end variations showed that 30 end
length isoforms are equally distributed between cells and exo-
somes, in contrast to miRNAs with 30 end NTAs that exhibited
differential distribution. The comparison of individual NTA types
(i.e., A, U, C, or G) to the sum of all reads with NTAs showed an
enrichment of adenylated miRNA isoforms in the cellular frac-
tions. In contrast, 30 end uridylated miRNAs were overrepre-
sented in exosomes of all LCL samples analyzed (Figure 3A).
To analyze whether the proportion of NTA-modified readsports 8, 1649–1658, September 25, 2014 ª2014 The Authors 1651
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Figure 2. MicroRNAs Are Nonrandomly Incorporated into Exosomes
(A) Volcano plot of significantly differentially abundant miRNAs in B cells and their secreted exosomes. Individual miRNAs from all samples were classified
according to the fold change (log2 of exo/cell ratio) at the x axis and plotted against their individual p value (y axis). Red dots: miRNAs in cells or exosomes
(p < 0.001); gray dots: miRNAs in cells or exosomes at p < 0.05. Vertical lines: >4-fold enrichment in cells (left) or exosomes (right).
(B and C) Significant overrepresented miRNAs in exosomes and cells from LCLs samples are depicted at the x axis with their read abundance exceeding
100 RPM (y axis on logarithmic scale). The error bars are the SD of the mean (n = 3); *p < 0.05; **p < 0.005; ***p < 0.0005; ns, not significant (Student’s t test);
FDR < 0.05 (see also Table S1C).
(D) miRNA detection in LCL cells and their matching exosomes by stem-loop-based qRT-PCR. Data represent DDCt value of technical duplicates normalized to
miR-92a Ct value from two independent experiments (n = 4; error bars ± SEM; p < 0.05).
(E) Human (LCLs) and EBV miRNAs were classified according to the fold change (log2 FC) between cellular and exosomal miRNAs; vertical dotted lines: miRNA
fractions with >4-fold enrichment in cells or in exosomes; red bars: virus miRNAs.(A, U, C, or G) differs significantly between cell and exosome
samples, eachmiRNA sequence with 30 end NTAswas extracted
from all 12 samples (LCLs: n = 6; BLs: n = 4; DLBCL: n = 2) and
fitted in a logistic model, which also corrected for the cell line1652 Cell Reports 8, 1649–1658, September 25, 2014 ª2014 The Aueffect (accounting for the paired design). The results suggest
that 30 end adenylated miRNA isoforms are preferentially re-
tained (chi-square test; p < 0.05), whereas all other NTAs are
preferentially released (30 end-U: chi-square test, p = 0.02;thors
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Figure 3. The 30 End Posttranscriptional
Modification Distinguishes Cellular and
Exosomal miRNA Repertoire
(A–C) Distribution of mature miRNAs and their
NTA-modified or unmodified isoforms in LCL
samples (biological triplicates) was compared
between cells and exosomes. The error bars are
the SD of the mean (LCL 1–3 samples; n = 3);
*p = 0.005 (Student’s t test).
(D and E) Frequency plots of a pairwise analysis of
30-A and 30-U isoforms. miRNAs found to be ex-
pressed in both cells and exosomes were selected
(at R300 reads, 100 miRNAs) for distribution
analysis of their adenylated and uridylated reads
expressed as percentage to the total of all NTA-
modified reads. Red circles: isoforms with higher
percentage in exosomes; purple circles: isoforms
with higher percentage in cells; white circles: equal
distribution.30 end-C: Fisher’s exact test, p = 0.04; 30 end-G: Fisher’s exact
test, p = 0.02; Figure S3B). It must be noted that nonadenylated
isoforms in exosomes may also be overrepresented in exo-
somes versus cells if their stability is lower in cells.
Apart from a global NTA distribution analysis, in three LCL
samples (i.e., biological triplicates), we observed that the
disparity of 30 end adenylated or uridylated miRNA isoforms be-
tween cells and exosomes was significant (p = 0.005; Student’s
t test; Figure 3A) and not observed for mature miRNA (miRBase-
based annotation) sequences (Figure 3B) or unmodified (elon-
gated or truncated) isoforms (Figure 3C). To examine the effect
of 30 end NTAs on distribution of individual miRNAs, we analyzed
100 abundantly expressed miRNAs in both cells and exosomes
and then matched cellular miRNAs to miRNAs in exosome frac-
tions for a pairwise analysis. The results demonstrated that
sequences of individual miRNAs with 30 end adenylation areCell Reports 8, 1649–1658, Sepmore associated with cellular fractions
(Figure 3D), whereas the same miRNAs
but with 30 end uridylation are more prone
to enrichment in exosomes (Figure 3E).
We thus conclude that the type of added
nucleotide, i.e., adenine or uridine, distin-
guishes the distribution in cells from
exosomes.
Deeper analysis of individual miRNA
sequences allowing more mismatches
and longer flanking regions (+6 nt) outside
the miRBase-annotated 30 end sequence
revealed that 30 ends of many miRNAs are
extended with more than one nontem-
plate nucleotide. To address whether the
number of posttranscriptionally added
nucleotides has a cumulative effect on
the distribution, we first calculated the
ratio of the fold changes between cells
and exosomes (defined as enrichment
coefficient; see Experimental Procedures)
for sequence reads with a particular NTAtype with nonmodified forms, taking into account the number
of added nucleotides. 30 end adenylation increases the probabil-
ity for retention, and this probability increases proportionally with
the number of added A’s (Figure 4A). Strikingly, triadenylated hu-
manmiRNAswere significantly more frequent in LCL cells than in
the corresponding exosomes (Figure 4A; p < 0.001; Student’s
t test), whereas triadenylated viral miRNAs are mainly detected
in LCL cell fractions (Figure S4). The association of 30 end adeny-
lation with an increase in cellular enrichment of viral miRNAs
further supports our prior suggestion that viral miRNAs exhibit
a strong tendency to remain cell associated (Figures 2E, S2B,
and S2C).
In contrast to 30 end adenylation, the disproportional occur-
rence of small RNAs with uridines at the 30 ends seems to define
exosomal RNA cargo (Figures 4A and 4B). To investigate
whether this is not a phenomenon restricted to B cells in culture,tember 25, 2014 ª2014 The Authors 1653
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Figure 4. The Extent of 30 End Adenylation Coincides with Cellular Enrichment whereas 30 End Uridylation Demarcates Exosomal Small RNA
Cargo
(A) Fraction of human miRNAs for which the adenylated reads (30 end-As) and the uridylated reads (30 end-Us) show enrichment in cells or in exosomes,
respectively. Enrichment coefficient defined as log2 fold change measures the enrichment of NTA reads found in exosomes or in cells when compared to the
canonical read. The error bars SD for LCLs (n = 3).
(B–D) 30 end uridylation rather than adenylation is more frequent on miRNA isoforms present in LCLs exosomes (B, left), BLs exosomes (B, right), and in human
urine exosomes (D). The bars represent theweightedmean of isoforms reads per sample (exosomes only) with 30 endNTA; nucleotide type indicated on the x axis;
error bars SD for LCLs (n = 3): *p = 0.005; BLs (n = 2): **p = 0.001; human urine (n = 6): **p < 0.0001 (Student’s t test). (C) Morphological characterization of EVs
isolated from human urine by transmission electron microscopy; scale bar 100 nm; magnification 330,000 (left panel) and 350,000 (right panel).
(E) Distribution of miR-486-5p between individual LCL cells and exosomes libraries. All sequencing reads that mapped to miR-486-5p were summed, and the
contribution of (iso)form types of miR-486-5p is expressed as percentage.
(F) Detection of canonical miR-486-5p, 30 end adenylated miR-486-5p (30-AAA), and 30 end uridylated miR-486-5p (30-UUU) in cellular (LCL1) and exosomal RNA
fractions by qPCR. Data represent mean cycle threshold (Ct) value of technical duplicates from two independent experiments (n = 2; error bars SD; *p < 0.01;
ns, not significant).we collected and purified naturally occurring EVs from human
urine (Figure 4C) using the same exosome-isolation protocol.
We sequenced the small RNA content from six urine exosomes1654 Cell Reports 8, 1649–1658, September 25, 2014 ª2014 The Ausamples derived from healthy individuals (Table S2). In full accor-
dance with 30 end uridylation-mediated miRNA isoforms distri-
bution observed in B cell exosomes (Figure 4B; p % 0.005;thors
Student’s t test), human urine exosomes are significantly en-
riched in 30 end uridylated miRNAs (Figure 4D; p < 0.0001;
Student’s t test). We conclude that 30 end uridylated miRNAs
are overrepresented in exosomes and that relative enrichment
of 30 end adenylated miRNA isoforms in cells increases with
the number of adenine nucleotides added to the 30 end of the
miRNA.
The Impact of 30 End NTAs on Exosomal Sorting of
Individual miRNAs
Whereas NTAs distinguish the miRNA distribution between cells
and exosomes, the impact of NTAs on individual miRNAsmay be
distinct. For example, 30 end uridylated reads of abundant exo-
some-enriched miRNAs 486-5p, 143-3p, and 101-3p show an
above-average percentage (38%) of all uridylated isoforms pre-
sent in exosomal fraction. Yet, miR-486-5p is seemingly equally
distributed at the mature miRNA level (Figure 4E; in gray).
Notably, 50% of all reads mapping to the mature miR-486-5p
sequence are either adenylated or uridylated isoforms (Fig-
ure 4E). When using the weighted means of all miRNAs in LCL
samples, we observed that triuridylated reads are nine times
more frequent in LCL exosomes compared to the cellular
content (p = 0.01; unpaired t test). We developed stem-loop-
RT-PCR primers that can distinguish miR-486-5p 30 end triade-
nylated and 30 end triuridylated isoforms. As expected, mature
miR-486-5p without 30 end nucleotide additions are equally
distributed, whereas 30 end triadenylated isoforms were en-
riched in cells (10-fold) and 30 end triuridylation (5-fold) in exo-
somes (Figure 4F). This independent approach supports the
RNA-seq data (Figure 4E) and demonstrates that different types
of 30 end posttranscriptional modifications are detectable by
RT-PCR. Thus, abundant miRNAs and their isoforms represent
key subpopulations with unique distribution properties, depend-
ing on the type and the extent of 30 end posttranscriptional
modification.
Apart from human and viral miRNAs, we found that adenyla-
tion and uridylation can also occur at the 30 ends of processed
fragments originating from small cytoplasmic Y RNAs (Fig-
ure S3C). Importantly, most of the 30-end-modified small RNA
molecules followed the same fate as miRNA isoforms in regard
to exosomal enrichment, suggesting that NTA modifications
act as a small RNA sorting signal beyond the class of miRNAs.
These results underscore the relevance of 30 end NTA and
expand our knowledge on diversity of small RNA substrates for
the nucleotidyl-transferase family of enzymes (Martin and Keller,
2007).
DISCUSSION
In this study, we addressed the composition of small ncRNAs in
humanB cells and exosomes in detail. We discovered that 30 end
posttranscriptional modifications define a critical distinction be-
tween miRNA distribution in cells and exosomes both globally
and at the individual miRNA level.
Unevenly distributed miRNA species between cells and their
released exosomes may be functionally relevant. Although
not studied here extensively, gene ontology analysis suggested
that cellular miRNAs repressing the mitogen-activated proteinCell Rekinase/phosphatidylinositol 3-kinase survival pathway are over-
represented in B cell exosomes (Figure S2A). Nonrandom
disposal of growth-restricting miRNAs is consistent with exoso-
mal sorting and release mechanisms for miRNAs in mammalian
cells. Indeed, sequence-dependent miRNA association with
exosome-incorporated RNA-binding proteins (RBPs) may pro-
mote their release (Villarroya-Beltri et al., 2013). Interestingly,
AGO2 is generally absent from exosomes (Vesiclepedia: http://
microvesicles.org/) and degraded by selective autophagy
when dissociated from miRNAs (Gibbings et al., 2012), suggest-
ing that miRNAs are secreted via exosomes by dissociating from
or associating with particular RBPs. This is distinct from obser-
vations in human plasma where cell-free AGO2/miRNA com-
plexes are detectable (Arroyo et al., 2011). Future studies should
answer whether nonrandom miRNA release has a biological
impact on gene regulation, which likely depends on multiple
additional factors. Indeed, the level and function of mature miR-
NAs are the result of different rates of both miRNA and target
transcription, processing location, and turnover (Ameres et al.,
2010; Baccarini et al., 2011).
In B cells, miR-486 is a highly abundant miRNA with an exten-
sive repertoire of adenylated and uridylated isoforms, but overall,
miR-486 seemed preferentially secreted by proliferating B cells.
Could this observation be reconciled in the multifaceted context
of miRNA activity and biological function? The apparent accu-
mulation of adenylated miR-486 isoforms may have physio-
logical relevance, as EBV-driven proliferating B cells require
ongoing nuclear factor (NF)-kB activation for their survival (Guas-
parri et al., 2008). Moreover, posttranscriptional modifications of
miR-486, for example by 30 uridylation, may indicate an antago-
nistic activity on NF-kB suppressors (Song et al., 2013). Whereas
the functional significance of these subtle 30 end modifications
are becoming unraveled (Boele et al., 2014; D’Ambrogio et al.,
2012; Jones et al., 2009; Katoh et al., 2009), their exact role in
selective miRNA turnover, abundance, and activity is currently
far from understood and complex (Ameres and Zamore, 2013).
Differential expression of miRNAs with terminal NTAs seems to
be associated with disease and can vary among different stages
of embryonic development (Fernandez-Valverde et al., 2010;
Wyman et al., 2011).
The observation that 30 end adenylated miRNA species are
relatively enriched in cells can be explained by 30 end adenyla-
tion increasing small RNA stability and activity (D’Ambrogio
et al., 2012; Katoh et al., 2009). Whereas adenylation seems
to induce stability (Katoh et al., 2009), in plants, Drosophila
and C. elegans 30 end addition of uracil residues renders the
RNAs less stable (Scott and Norbury, 2013). In mammalian
cells, ZCCHC11, a terminal uridyltransferase also known as
TUT4, mediates terminal uracil additions of miR-26a, thereby
abolishing its function, albeit its relative abundance appears
unaffected (Jones et al., 2009). Enrichment of 30 uridylated miR-
NAs in exosomes may thus be explained by preferential release
or could be due to a high turnover in cells compared to exo-
somes. In addition, uridityl transferase activity in exosomes
themselves may be a cause of 30 uridylation, although quantita-
tive proteomic analysis argues against the presence of such
enzymes in exosomes (Exocarta: http://www.exocarta.org/). It
thus remains to be seen whether uridyl transferases are presentports 8, 1649–1658, September 25, 2014 ª2014 The Authors 1655
in EVs originating from different cell types. Interestingly, mature
miR-451 (i.e., without NTAs) is highly abundant in exosomes,
which argues against the conclusion that uridylation favors
miRNA release. Provocatively, however, the mature miR-451
30 end contains a UUU sequence, suggesting that the presence
of a uracil residue itself is sufficient as sorting signal. Although
additional explanations cannot be ruled out, we speculate that
30 adenylation of defined miRNA species favors cellular reten-
tion, whereas 30 uridylation may promote the release of miRNAs
and processed Y RNAs.
Our work provides a strong rationale for studying 30 end post-
transcriptional modifications in combination with exosome
biology. We and others recently provided evidence that selec-
tive secretion of signaling proteins via exosomes has an antag-
onizing effect on intracellular signaling pathways (Chairoungdua
et al., 2010; Verweij et al., 2013). The notion that miRNA activity
is dependent on the presence of selective mRNA targets and
coupled to incorporation into exosomes yields new perspec-
tives on gene regulation control. For example, deregulation of
exosome production, as observed in most tumor cells (Balaj
et al., 2011), may also affect miRNA function. In addition, the
identification of specific modified RNAs in EVs isolated from
human body fluids such as urine may also be valuable for
diagnostic purposes. Deeper understanding of the underlying
mechanism(s) controlling small ncRNA selection and release
via exosomes may advance future biofluid-based diagnostic
applications.EXPERIMENTAL PROCEDURES
Preparation of RNA Samples for Deep Sequencing
For each cellular or exosomal sample, an equal amount of input RNA (600 ng
of RNA) was prepared for sequencing using the TruSeq small RNA sample
prep following manufacturer’s instruction (Illumina). Sequence libraries were
measured on an Agilent 2100 Bioanalyzer (Agilent Technologies), and up to
12 samples were equimolarly combined per run. Sequencing was performed
on a HiSeq 2000 (Illumina) paired-end 100-cycle (PE100) run.
Detection of RNA Reads with Nontemplated Nucleotides Additions
and Statistical Analysis
miRNA isoforms or isomiRs are retrieved by stepwise analysis depicted in
Figure S3A. Briefly, for detection of NTAs at 30 termini of mapped RNA ele-
ments, we compared the read sequence to the aligned pre-miRNA
sequence, starting at the nucleotide position 18 of the read. If the algorithm
finds a mismatch position between the read and the pre-microRNA after
position 18, the read is further analyzed from the mismatch position to the
end of the read whereas all following nucleotides need be equal to the
one at the mismatch position. If a different nucleotide is encountered,
the search is continued at the next mismatch position or the read is tagged
as non-NTA. After detecting all NTA reads, we calculate the weighted mean
per sample by dividing the number of reads ending with NTAs of a given
nucleobase (A, U, C, and G) by total number of reads mapped to miRNAs.
Per miRNA and per sample, we computed the total number of reads ending
with NTAs of a given nucleobase, in addition to the total number of reads
mapped to that miRNA. So, for each nucleobase, we could use the number
of reads, in relation to the total, in a logistic regression model that also
included the sample type (cell or exosome) as well as the cell line (accounting
for the paired design). Based upon this model, we extracted p values for the
difference between proportions of miRNA counts with NTA of a given nucle-
otide and between cells and exosomes. After fitting this model per miRNA,
Benjamini-Hochberg’s FDR is applied to the p values in order to correct
for multiple testing.1656 Cell Reports 8, 1649–1658, September 25, 2014 ª2014 The AuDistribution of Small RNAs with Nontemplated Nucleotides
Additions
The assessment of the distribution of posttranscriptionally modified reads
(NTAs) between cells and exosomes was performed as following. To test if
miRNA-related reads have a tendency either to be enriched in exosomes
or to be enriched in cells, we compared those to the baseline distribution
tendency of the given miRNA (defined by canonical reads). We define the
enrichment coefficient by computing the ratio of the fold changes
between exosomes and cells for reads ending with a certain type of nontem-
plated nucleotide (defined as NTA) and those without terminal modification
(defined as noNTA). The coefficient will be close to 0, for which the NTA
reads and the non-NTA reads of a small ncRNA sequence have the equal
tendency to be associated with cells and with exosomes. It will be positive
if the NTA reads have a stronger tendency to be enriched in exosomes
compared to the non-NTA reads. Finally, a negative coefficient indicates
that NTA reads have a stronger tendency to be enriched in cells compared
to non-NTA reads.
EC= log2
 
RCExo
RCcell

Baseline
!
Baseline=
RCcanonicalexo
RCcanonicalcell
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